Alnylam Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $178.0M | $137.5M |
| FY2010 | — | $158.2M | $74.6M |
| FY2011 | — | $118.0M | $70.2M |
| FY2012 | — | $134.1M | $51.4M |
| FY2013 | — | $270.3M | $53.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $178.0M | $137.5M |
| FY2010 | — | $158.2M | $74.6M |
| FY2011 | — | $118.0M | $70.2M |
| FY2012 | — | $134.1M | $51.4M |
| FY2013 | — | $270.3M | $53.2M |